Identification Generic Name (2R)-2-Acetamido-3-(octadecyloxy)propyl 2-(methylsulfanyl)ethyl hydrogen phosphate DrugBank Accession Number DB04112 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 Download  MOL SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2R)-2-Acetamido-3-(octadecyloxy)propyl 2-(methylsulfanyl)ethyl hydrogen phosphate (DB04112) ×  Close Weight Average: 539.749  Monoisotopic: 539.340945667  Chemical Formula C 26 H 54 NO 6 PS Synonyms 1-Octadecyl-2-acetamido-2-deoxy-SN-glycerol-3-phosphoethylmethyl sulfide Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Phospholipase A2, membrane associated Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as phosphoethanolamines. These are compounds containing a phosphate linked to the second carbon of an ethanolamine. Kingdom Organic compounds Super Class Organic acids and derivatives Class Organic phosphoric acids and derivatives Sub Class Phosphate esters Direct Parent Phosphoethanolamines Alternative Parents Dialkyl phosphates  /  Acetamides  /  Secondary carboxylic acid amides  /  Sulfenyl compounds  /  Dialkylthioethers  /  Dialkyl ethers  /  Organonitrogen compounds  /  Organic oxides  /  Hydrocarbon derivatives  /  Carbonyl compounds Substituents Acetamide  /  Aliphatic acyclic compound  /  Alkyl phosphate  /  Carbonyl group  /  Carboxamide group  /  Carboxylic acid derivative  /  Dialkyl ether  /  Dialkyl phosphate  /  Dialkylthioether  /  Ether Molecular Framework Aliphatic acyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key ZULTVWFLRZJENJ-AREMUKBSSA-N InChI InChI=1S/C26H54NO6PS/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-31-23-26(27-25(2)28)24-33-34(29,30)32-21-22-35-3/h26H,4-24H2,1-3H3,(H,27,28)(H,29,30)/t26-/m1/s1 IUPAC Name [(2R)-2-acetamido-3-(octadecyloxy)propoxy][2-(methylsulfanyl)ethoxy]phosphinic acid SMILES [H]N([C@H](COCCCCCCCCCCCCCCCCCC)COP(O)(=O)OCCSC)C(C)=O References General References Not Available External Links PubChem Compound 5288635 PubChem Substance 46506883 ChemSpider 4450758 ZINC ZINC000014881051 PDBe Ligand INB PDB Entries 1ayp Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.000349 mg/mL ALOGPS logP 6.11 ALOGPS logP 7.11 Chemaxon logS -6.2 ALOGPS pKa (Strongest Acidic) 1.92 Chemaxon pKa (Strongest Basic) -1.6 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 94.09 Å 2 Chemaxon Rotatable Bond Count 27 Chemaxon Refractivity 147.14 m 3 ·mol -1 Chemaxon Polarizability 65.12 Å 3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.7114 Blood Brain Barrier + 0.9087 Caco-2 permeable - 0.6319 P-glycoprotein substrate Substrate 0.5192 P-glycoprotein inhibitor I Non-inhibitor 0.6232 P-glycoprotein inhibitor II Non-inhibitor 0.8781 Renal organic cation transporter Non-inhibitor 0.9514 CYP450 2C9 substrate Non-substrate 0.8357 CYP450 2D6 substrate Non-substrate 0.8093 CYP450 3A4 substrate Non-substrate 0.5 CYP450 1A2 substrate Non-inhibitor 0.827 CYP450 2C9 inhibitor Non-inhibitor 0.8166 CYP450 2D6 inhibitor Non-inhibitor 0.9045 CYP450 2C19 inhibitor Non-inhibitor 0.7071 CYP450 3A4 inhibitor Non-inhibitor 0.7477 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9577 Ames test Non AMES toxic 0.6566 Carcinogenicity Non-carcinogens 0.7883 Biodegradation Not ready biodegradable 0.9207 Rat acute toxicity 2.5871 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9256 hERG inhibition (predictor II) Non-inhibitor 0.7726    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Phospholipase A2, membrane associated Kind Protein Organism Humans Pharmacological action Unknown General Function Phospholipid binding Specific Function Thought to participate in the regulation of the phospholipid metabolism in biomembranes including eicosanoid biosynthesis. Catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-ph... Gene Name PLA2G2A Uniprot ID P14555 Uniprot Name Phospholipase A2, membrane associated Molecular Weight 16082.525 Da References Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [ Article ]  Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at June 13, 2005 13:24 / Updated at July 11, 2020 03:42 